“Clearly, the women who were assigned into the Coloplast Altis group ‘drew the short straw’ as their sexual function was placed at risk as a result of this device when compared with full-length mid-urethral slings” states Greg Vigna, MD, JD, national mid-urethral sling attorney.

Dr. Greg Vigna, national mid-urethral sling attorney, states, “Level 1 Evidence from the ‘Single-incision Mini-sling versus Standard Synthetic Mid-urethral Slings for Surgical Treatment of Stress Urinary Incontinence in Women: The SIMS RCT’ reported a 20 percent risk of dyspareunia at 15 months and a 14 percent risk of coital incontinence for women in the Altis group. This is brutal news for the women assigned to the Altis group and for women implanted with this device outside of this study.”

Read the SIMS trial (Health Technology Assessment, No. 26.47): https://www.ncbi.nlm.nih.gov/books/NBK587586

What did the SIMS RCT report regarding DYSPAREUNIA (pg. 51)? See Table 17 (Part 1).

What did the SIMS RCT report regarding COITAL INCONTINENCE (pg. 52)? See Table 17 (Part 2).

Dr. Vigna adds, “We are involved in discovery in cases filed in State Courts across the country for women who unfortunately drew the short straw when their doctors selected the Coloplast Altis device. Our position is that this device is too stiff and causes an unacceptable risk of dyspareunia and coital incontinence compared to other slings.”

Dr. Vigna concludes, “Polypropylene transobturator slings perform poorly compared to full-length mid-urethral slings made of PVDF. Mid-urethral slings made with PVDF represent a safer alternative design currently available across the world, but still not available to women in the United States.”

Read “Polypropylene and Polyvinylidene Fluoride Transobturator Slings for the Treatment of Female Stress Urinary Incontinence: 1-Year Outcomes from a Multicentre Randomized Trial” published in Neurourology and Urodynamics. Volume 40, Issue 1, pg. 475-482: https://onlinelibrary.wiley.com/doi/full/10.1002/nau.24586

Vigna Law Group is investigating the red flag warning symptoms of neurological injury and catastrophic pain syndromes caused by mid-urethral slings, such as the Obtryx and the Altis device for physician negligence and/or product claims against the manufacturers of the device, including:

1) “Other: Non-pelvic pain” including anatomic groin pain (inner leg pain), thigh pain, and hip pain
2) “Pelvic/Urogenital (groin) pain”: Pain not including the inner leg, thigh, or hip including:
a) Inability to wear tight pants
b) Clitoral pain or numbness
c) Severe pain that makes vaginal penetration impossible
d) Tailbone pain
e) Anorectal pain
f) Painful bladder
g) Pain with sitting

Dr. Vigna is a California and Washington DC lawyer who focuses on catastrophic pain syndromes caused by mini-slings such as the Coloplast Altis sling and Boston Scientific Solyx sling, including pudendal neuralgia and obturator neuralgia. He represents women with the Ben Martin Law Group, a national pharmaceutical injury law firm in Dallas, Texas. The attorneys are product liability and medical malpractice attorneys who represent neurological injuries across the country.

Click here for a free book on Vaginal Mesh Pain.